In an interview with the Korean Economic Daily, CEO of Wellmarker Bio (Dong-Hoon Jin) shared approval news of WM-S1-030 and plans on clinical trials. Please click on the link below (Language: Korean).
Link: https://www.wowtv.co.kr/Component/TvPlayer/PlayTvReplay?num=124092